查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451647

2024-2032 年按产品（瓶子、西林瓶、安瓿、药筒和注射器等）、药物类型（仿製药、品牌药、生物製品）、应用（口服、注射、鼻腔等）和地区分類的医药玻璃包装市场报告

Pharmaceutical Glass Packaging Market Report by Product (Bottles, Vials, Ampoules, Cartridges and Syringes, and Others), Drug Type (Generic, Branded, Biologic), Application (Oral, Injectable, Nasal, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年全球药用玻璃包装市场规模达94亿美元。展望未来， IMARC Group预计到2032年市场规模将达到164亿美元，2024-2032年复合年增长率（CAGR）为6.2%。对药品的需求不断增长，监管机构对药品包装实施严格的法规和品质标准，对产品安全和完整性的日益关注，以及人们对玻璃相对于替代材料的优势的认识不断增强，是推动市场发展的一些因素。

药用玻璃包装对于确保药品的安全性、完整性和有效性至关重要。它涉及使用专门设计的玻璃容器和密封件来保护药物免受可能损害其品质的外部因素的影响，例如水分、光线和化学相互作用。它具有许多优点，包括出色的阻隔性、惰性和透明度，可以目视检查内容物。玻璃容器还可以抵抗温度变化并具有较长的保质期，使其成为储存和保存药品的理想选择。此外，玻璃是一种非反应性材料，可以最大限度地减少浸出或污染的风险，并保持药物的稳定性和纯度。玻璃的多功能性允许多种包装选择，包括小瓶、安瓿、瓶子和注射器，以满足不同的剂型和给药途径。药用玻璃包装须遵守严格的品质控制措施和监管标准，以确保药品的安全性和可靠性，使其成为製药业对病患照护和产品完整性承诺的重要组成部分。

全球市场的主要驱动力是对永续性的日益重视。随着环保意识的增强，製药业对永续包装解决方案的需求不断增加。玻璃包装被认为比塑胶替代品更环保。此外，生物製药产业（包括生物製品、疫苗和基因疗法）的快速成长需要专门的包装来维持这些敏感产品的稳定性和功效。玻璃容器提供卓越的防污染保护并保持生物製药的完整性，从而推动了对药用玻璃包装的需求。除此之外，对病人安全的日益关注正在刺激市场。此外，仿製药和非处方药市场的不断扩大刺激了对药用玻璃包装的需求。此外，玻璃製造和包装技术的快速创新提高了药用玻璃包装的能力和功能。例如，玻璃成型技术和表面处理的进步提高了玻璃容器的强度和耐用性。此外，RFID标籤和热敏标籤等智慧包装功能的整合增强了药品的可追溯性和监控能力，推动了玻璃包装解决方案的采用。

药用玻璃包装市场趋势/驱动因素：

日益关注防伪措施

对防伪措施的日益关注极大地促进了市场的成长。假药对病人安全和公共卫生构成重大风险，促使监管机构和製药公司采取强而有力的措施来解决这个问题。玻璃包装具有难以复製或篡改的固有防伪功能，使其成为药品的理想选择。此外，玻璃容器可以采用独特的压花、全像标籤和隐藏标记作为认证和识别措施。这些功能有助于验证药品的真实性并防止它们被假冒。透过使用玻璃包装，製药公司可以向患者和医疗保健提供者保证他们收到的药物是正品和安全的。此外，保护患者健康、维护品牌声誉和遵守监管要求的需求推动了玻璃包装作为防伪措施的迅速采用。随着防伪关注度的加强，药用玻璃包装的需求预计将成长，有助于市场的扩张。

扩大全球製药业

全球不断扩张的製药业是市场成长的关键驱动力。由于人口成长、医疗保健支出增加和医疗技术进步，製药业正在经历大幅成长。这种成长转化为对药品的更高需求，进而推动对包括玻璃容器在内的包装解决方案的需求。此外，玻璃包装具有众多优点，非常适合製药业。其优异的阻隔性能可保护药物免受可能损害其品质和稳定性的外部因素的影响，例如水分、光和化学相互作用。玻璃还具有惰性，可确保药物的完整性和纯度。此外，玻璃容器具有透明度，可轻鬆目视检查内容物。随着製药业在全球的扩张，对药用玻璃包装的需求不断增加，以满足对维持药物功效和安全性的包装解决方案不断增长的需求。因此，在不断扩大的製药行业及其对可靠和高品质包装选择的需求的推动下，市场正在经历成长。

延长药品保质期的需求不断增长

延长药品保质期的需求不断增长正在刺激市场。几种药物，特别是敏感製剂，需要更长的保质期才能保持其效力和功效。玻璃包装在这方面非常有优势。玻璃容器可提供卓越的保护，防止外部因素（例如光、湿气和氧气）随着时间的推移而降解药物。玻璃具有出色的阻隔性能，可以防止这些元素的进入，有助于延长药物的保质期。此外，玻璃的惰性性质确保药物保持稳定并且不受与容器相互作用的影响。玻璃还具有不渗透气体和蒸汽的特性，这进一步有助于保持药品的完整性。此外，玻璃是一种非反应性材料，可最大限度地降低浸出或污染的风险。此外，随着製药业努力确保药品的使用寿命和质量，对药用玻璃包装的需求不断增加。製药公司依靠玻璃容器提供必要的保护和稳定性，以延长药物的保质期，从而推动市场的成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药用玻璃包装市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 瓶子
    • 市场走向
    • 市场预测
  • 小瓶
    • 市场走向
    • 市场预测
  • 安瓿
    • 市场走向
    • 市场预测
  • 药筒和注射器
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按药物类型

  • 通用的
    • 市场走向
    • 市场预测
  • 品牌化
    • 市场走向
    • 市场预测
  • 生物製剂
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 口服
    • 市场走向
    • 市场预测
  • 可注射
    • 市场走向
    • 市场预测
  • 鼻腔
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Ardagh Group SA
    • Beatson Clark
    • Bormioli Pharma SpA
    • Corning Incorporated
    • Gerresheimer AG
    • Nipro Corporation
    • Piramal Enterprises Ltd.
    • Schott AG
    • SGD Pharma
    • Shandong Pharmaceutical Glass Co. Ltd.
    • Sisecam (Turkiye Is Bankasi AS)
    • Stolzle-Oberglas GmBH
    • West Pharmaceutical Services Inc.
Product Code: SR112024A5094

The global pharmaceutical glass packaging market size reached US$ 9.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. The increasing demand for pharmaceutical products, the stringent regulations and quality standards imposed by regulatory authorities on pharmaceutical packaging, the rising focus on product safety and integrity, and the growing awareness regarding the advantages of glass over alternative materials are some of the factors propelling the market.

Pharmaceutical glass packaging is crucial in ensuring pharmaceutical products' safety, integrity, and efficacy. It involves using specially designed glass containers and closures to protect drugs from external factors that could compromise their quality, such as moisture, light, and chemical interactions. It offers numerous advantages, including excellent barrier properties, inertness, and transparency, allowing for the visual inspection of the contents. Glass containers also resist temperature changes and have a long shelf life, making them ideal for storing and preserving pharmaceuticals. Additionally, glass is a non-reactive material that minimizes the risks of leaching or contamination, maintaining the stability and purity of medications. The versatility of glass allows for various packaging options, including vials, ampoules, bottles, and syringes, catering to different dosage forms and administration routes. Pharmaceutical glass packaging is subject to stringent quality control measures and regulatory standards to ensure the safety and reliability of medicines, making it a critical component of the pharmaceutical industry's commitment to patient care and product integrity.

The global market is majorly driven by the increasing emphasis on sustainability. With the growing environmental consciousness, there is a rising demand for sustainable packaging solutions in the pharmaceutical industry. Glass packaging is considered to be more environmentally friendly than plastic alternatives. Furthermore, the rapid growth of the biopharmaceutical sector, including biologics, vaccines, and gene therapies, requires specialized packaging that can maintain the stability and efficacy of these sensitive products. Glass containers offer superior protection against contamination and preserve the integrity of biopharmaceuticals, thus driving the demand for pharmaceutical glass packaging. Apart from this, the escalating focus on patient safety is catalyzing the market. Moreover, the expanding market for generic drugs and OTC medications fuels the demand for pharmaceutical glass packaging. Besides, the rapid innovations in glass manufacturing and packaging technologies have improved the capabilities and functionalities of pharmaceutical glass packaging. For instance, advancements in glass forming techniques and surface treatments have enhanced the strength and durability of glass containers. Additionally, the integration of smart packaging features, such as RFID tags and temperature-sensitive labels, provides enhanced traceability and monitoring of pharmaceutical products, driving the adoption of glass packaging solutions.

Pharmaceutical Glass Packaging Market Trends/Drivers:

Increasing focus on anti-counterfeiting measures

The increasing focus on anti-counterfeiting measures is significantly contributing to the market growth. Counterfeit drugs pose significant risks to patient safety and public health, prompting regulatory authorities and pharmaceutical companies to take robust measures to combat this issue. Glass packaging offers inherent anti-counterfeiting features that are difficult to replicate or tamper with, making it an ideal choice for pharmaceutical products. Furthermore, the glass containers can incorporate unique embossing, holographic labels, and covert markings as authentication and identification measures. These features help verify the authenticity of pharmaceutical products and protect them from counterfeiting. By using glass packaging, pharmaceutical companies can assure patients and healthcare providers that the medications they receive are genuine and safe. Moreover, the rapid adoption of glass packaging as an anti-counterfeiting measure is driven by the need to safeguard patient health, maintain brand reputation, and comply with regulatory requirements. As the focus on anti-counterfeiting intensifies, the demand for pharmaceutical glass packaging is expected to grow, thereby contributing to the expansion of the market.

Expanding pharmaceutical industry worldwide

The expanding pharmaceutical industry worldwide is a key driver of the growth in the market. The pharmaceutical sector is experiencing substantial growth due to population growth, increasing healthcare spending, and advancements in medical treatments. This growth translates into a higher demand for pharmaceutical products, which, in turn, drives the demand for packaging solutions, including glass containers. Furthermore, glass packaging offers numerous advantages that make it highly suitable for the pharmaceutical industry. Its excellent barrier properties protect drugs from external factors that could compromise their quality and stability, such as moisture, light, and chemical interactions. Glass is also inert, ensuring the integrity and purity of medications. Additionally, glass containers provide transparency, allowing for easy visual inspection of the contents. With the expansion of the pharmaceutical industry worldwide, there is an increased need for pharmaceutical glass packaging to meet the growing demand for packaging solutions that maintain the efficacy and safety of medications. As a result, the market is experiencing growth, driven by the expanding pharmaceutical industry and its requirements for reliable and high-quality packaging options.

Rising need to extend the shelf life of medicinal products

The rising need to extend the shelf life of medicinal products is catalyzing the market. Several medications, particularly sensitive formulations, require a longer shelf life to maintain their potency and efficacy. Glass packaging is highly advantageous in this regard. Glass containers offer exceptional protection against external factors that can degrade pharmaceutical products over time, such as light, moisture, and oxygen. Glass has excellent barrier properties that prevent the ingress of these elements, helping to extend the shelf life of medications. Furthermore, the inert nature of glass ensures that drugs remain stable and unaffected by interactions with the container. Glass is also impermeable to gases and vapors, which further helps preserve the integrity of pharmaceutical products. Moreover, glass is a non-reactive material, minimizing the risk of leaching or contamination. Besides, as the pharmaceutical industry strives to ensure the longevity and quality of medicinal products, the demand for pharmaceutical glass packaging increases. Pharmaceutical companies rely on glass containers to provide the necessary protection and stability required to extend the shelf life of their medications, thus driving the growth of the market.

Pharmaceutical Glass Packaging Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical glass packaging market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, drug type, and application.

Breakup by Product:

Bottles

Vials

Ampoules

Cartridges and Syringes

Others

Bottles dominate the market

The report has provided a detailed breakup and analysis of the market based on product. This includes bottles, vials, ampoules, cartridges and syringes, and others. According to the report, bottles represented the largest segment.

Bottles are widely used in the pharmaceutical industry for packaging liquid medications, such as syrups, suspensions, and oral solutions. The demand for pharmaceutical bottles is driven by the increasing consumption of liquid medications, the need for accurate dosing, and the preference for child-resistant packaging.

On the contrary, vials are primarily used for packaging injectable drugs, including vaccines, biologics, and parenteral medications. The growing demand for biopharmaceuticals and the rise in chronic diseases requiring injectable therapies contribute to expanding the vials segment in the market. Moreover, ampoules are small, sealed glass containers for packaging single-dose injectable drugs. They offer excellent product protection, ensuring sterility and preventing contamination. The need for precise dosing, prolonged shelf life, and the increasing demand for aseptic packaging solutions drive the ampoules segment.

Besides, cartridges and syringes are utilized for packaging and administering pre-filled drugs, such as insulin and other injectables. The convenience, accuracy, and ease of use associated with pre-filled cartridges and syringes contribute to their growing demand, driven by factors such as the rise in chronic diseases and the need for self-administered medications.

Breakup by Drug Type:

Generic

Branded

Biologic

Generic holds the largest share in the market

A detailed breakup and analysis of the market based on the drug type have also been provided in the report. This includes generic, branded, and biologic. According to the report, generic accounted for the largest market share.

The increasing demand for generic drugs, driven by cost-effectiveness and patent expirations, fuels the growth of the market. Generic drugs require reliable and high-quality packaging solutions to maintain their efficacy, stability, and shelf life. Glass containers provide excellent protection against degradation factors, ensuring the integrity and potency of generic medications.

On the other hand, branded drugs, with their unique formulations and therapeutic properties, necessitate specialized packaging to maintain their identity and market appeal. Pharmaceutical glass packaging offers a premium and trustworthy image for branded drugs, enhancing brand recognition and patient confidence. The use of glass containers conveys a sense of quality and reliability to consumers, thus contributing to the market.

Moreover, the increasing prominence of biologics, including vaccines, monoclonal antibodies, and gene therapies, propels the demand for pharmaceutical glass packaging. Biologic drugs are often sensitive to environmental factors and require stringent storage and packaging conditions. Glass containers provide superior protection against light, oxygen, and moisture, ensuring the stability and efficacy of biologic medications.

Breakup by Application:

Oral

Injectable

Nasal

Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes oral, injectable, nasal, and others.

The oral segment involves packaging medications in tablets, capsules, and syrups for ingestion. The demand for pharmaceutical glass packaging in the oral segment is driven by factors such as the increasing consumption of oral medications, the need for moisture and contamination protection, and the preference for child-resistant and tamper-evident packaging.

Furthermore, the injectable segment involves packaging drugs administered via injections, including vaccines, biologics, and parenteral medications. Glass containers are preferred in this segment due to their superior properties in maintaining sterility, preventing contamination, and preserving the stability of injectable drugs. The growth of the injectable segment is fueled by the rise in chronic diseases, the need for accurate dosing, and advancements in biopharmaceuticals.

Moreover, the nasal segment encompasses medications delivered through nasal sprays or inhalers. Pharmaceutical glass packaging in the nasal segment provides protection against light, moisture, and oxygen, preserving the integrity and efficacy of nasal medications. The growing prevalence of respiratory diseases and the demand for convenient and precise nasal drug delivery contribute to the expansion of this segment.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The pharmaceutical industry in North America, particularly in the United States, is well-established and technologically advanced. The region has a high demand for pharmaceutical glass packaging due to robust healthcare infrastructure, a large consumer base, and stringent regulatory standards. Additionally, the increasing focus on patient safety and the need for reliable packaging solutions contribute to the growth of the North American market.

Furthermore, the Asia Pacific region is witnessing rapid growth in the pharmaceutical industry, driven by factors such as a large population, rising healthcare expenditure, and increasing generic drug manufacturing. Countries like China and India are emerging as major players in the pharmaceutical sector, leading to a surge in demand for pharmaceutical glass packaging. The region's growing middle-class population, urbanization, and expanding healthcare access further contribute to the market growth. Additionally, the rising emphasis on product safety, advancements in drug manufacturing technologies, and the adoption of international quality standards fuel the demand for pharmaceutical glass packaging in Asia.

Competitive Landscape:

Top companies play a crucial role in driving the growth of the market through their innovative solutions, extensive product portfolios, and strong market presence. These companies invest heavily in research and development to introduce advanced glass packaging technologies that cater to the evolving needs of the pharmaceutical industry. They continuously enhance the barrier properties, durability, and design of their glass containers to ensure optimal protection and preservation of pharmaceutical products. Moreover, these companies focus on providing a wide range of customization options, such as different sizes, shapes, closures, and labeling solutions, to meet the specific requirements of pharmaceutical companies. This flexibility allows pharmaceutical manufacturers to package their products efficiently while maintaining brand identity and complying with regulatory standards. Additionally, through collaborations and partnerships, top companies establish strong relationships with pharmaceutical manufacturers. They provide comprehensive packaging solutions, including design consultation, supply chain management, and technical support, which contribute to the growth of the market by offering integrated and streamlined packaging services. Furthermore, these companies actively engage in sustainability initiatives, promoting eco-friendly glass packaging solutions. By prioritizing recyclability, they align with the growing consumer and industry demand for environmentally responsible packaging options.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Ardagh Group S.A

Beatson Clark

Bormioli Pharma S.p.A.

Corning Incorporated

Gerresheimer AG

Nipro Corporation

Piramal Enterprises Ltd.

Schott AG

SGD Pharma

Shandong Pharmaceutical Glass Co. Ltd.

Sisecam (Turkiye Is Bankasi A.S.)

Stolzle-Oberglas GmBH

West Pharmaceutical Services Inc.

Recent Developments:

In 2020, Ardagh Group S.A., a leading global packaging company, collaborated with B.D. (Becton, Dickinson, and Company), a global medical technology company to develop and supply high-quality glass vials for COVID-19 vaccines. This collaboration aimed to support global vaccination efforts by providing secure and reliable vaccine packaging solutions.

In 2021, Beatson Clark, a UK-based glass packaging manufacturer, announced an investment of £2 million in its glass production facility to expand its pharmaceutical glass packaging capabilities. This investment allowed Beatson Clark to enhance its manufacturing processes, increase production capacity, and introduce advanced technologies for pharmaceutical glass packaging.

In 2019, Bormioli Pharma S.p.A, an Italian company specializing in pharmaceutical glass packaging, launched an advanced glass container called "Type I Plus" to address the specific needs of sensitive pharmaceutical products. The Type I Plus glass offers enhanced chemical resistance and protection against delamination, making it suitable for storing and preserving highly reactive medications.

Key Questions Answered in This Report

  • 1. What was the size of the global pharmaceutical glass packaging market in 2023?
  • 2. What is the expected growth rate of the global pharmaceutical glass packaging market during 2024-2032?
  • 3. What are the key factors driving the global pharmaceutical glass packaging market?
  • 4. What has been the impact of COVID-19 on the global pharmaceutical glass packaging market?
  • 5. What is the breakup of the global pharmaceutical glass packaging market based on the product?
  • 6. What is the breakup of the global pharmaceutical glass packaging market based on the drug type?
  • 7. What are the key regions in the global pharmaceutical glass packaging market?
  • 8. Who are the key players/companies in the global pharmaceutical glass packaging market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Glass Packaging Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Bottles
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Vials
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ampoules
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cartridges and Syringes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Generic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Branded
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biologic
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injectable
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ardagh Group S.A
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Beatson Clark
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bormioli Pharma S.p.A.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Corning Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Gerresheimer AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Nipro Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Piramal Enterprises Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Schott AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 SGD Pharma
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Shandong Pharmaceutical Glass Co. Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Sisecam (Turkiye Is Bankasi A.S.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Stolzle-Oberglas GmBH
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 West Pharmaceutical Services Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmaceutical Glass Packaging Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Glass Packaging Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pharmaceutical Glass Packaging Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Pharmaceutical Glass Packaging Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Pharmaceutical Glass Packaging Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Pharmaceutical Glass Packaging Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pharmaceutical Glass Packaging (Bottles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Pharmaceutical Glass Packaging (Bottles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Pharmaceutical Glass Packaging (Vials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Pharmaceutical Glass Packaging (Vials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Pharmaceutical Glass Packaging (Ampoules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Pharmaceutical Glass Packaging (Ampoules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Pharmaceutical Glass Packaging (Cartridges and Syringes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Pharmaceutical Glass Packaging (Cartridges and Syringes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Pharmaceutical Glass Packaging (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Pharmaceutical Glass Packaging (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Pharmaceutical Glass Packaging (Generic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Pharmaceutical Glass Packaging (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Pharmaceutical Glass Packaging (Branded) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Pharmaceutical Glass Packaging (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Pharmaceutical Glass Packaging (Biologic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Pharmaceutical Glass Packaging (Biologic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Pharmaceutical Glass Packaging (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Pharmaceutical Glass Packaging (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Pharmaceutical Glass Packaging (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Pharmaceutical Glass Packaging (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Pharmaceutical Glass Packaging (Nasal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Pharmaceutical Glass Packaging (Nasal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Pharmaceutical Glass Packaging (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Pharmaceutical Glass Packaging (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Pharmaceutical Glass Packaging Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Pharmaceutical Glass Packaging Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Pharmaceutical Glass Packaging Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Pharmaceutical Glass Packaging Industry: SWOT Analysis
  • Figure 82: Global: Pharmaceutical Glass Packaging Industry: Value Chain Analysis
  • Figure 83: Global: Pharmaceutical Glass Packaging Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Glass Packaging Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Glass Packaging Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Glass Packaging Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Glass Packaging Market: Key Players